Amendment 257 to article 3, paragraph 1, point 5
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Article 3, § 1, point 5 – Am 257
Adopted
- For
- 325
- Against
- 284
- Abstained
- 33
roll-call vote at 12:46 · 51% of votes cast in favour
Roll call requested by Renew
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 38 | 0 | 0 | 38 | For |
| Greens | 51 | 0 | 0 | 51 | For |
| S&D | 115 | 1 | 2 | 118 | For |
| Renew | 58 | 0 | 8 | 66 | For |
| EPP | 29 | 139 | 7 | 175 | Against |
| ECR | 0 | 64 | 6 | 70 | Against |
| Patriots | 27 | 51 | 0 | 78 | Divided |
| ESN | 0 | 20 | 3 | 23 | Against |
| No group | 7 | 9 | 7 | 23 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
642 MEPs voted. Open a group, or filter above.
The Left 38 MEPs
Greens 51 MEPs
S&D 118 MEPs
Renew 66 MEPs
EPP 175 MEPs
ECR 70 MEPs
Patriots 78 MEPs
ESN 23 MEPs
No group 23 MEPs
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.